NCT02151682View on ClinicalTrials.gov

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 29, 2015

Primary Completion Date

October 18, 2017

Study Completion Date

October 15, 2018

Conditions
Pain
Interventions
DRUG

Tapentadol prolonged release

DRUG

Morphine prolonged release

Trial Locations (23)

1094

HU001, Budapest

1606

BG001, Sofia

BG006, Sofia

3000

BE001, Leuven

4001

BG004, Plovdiv

5800

BG005, Pleven

10126

IT003, Turin

29609

FR004, Brest

47005

ES003, Valladolid

54500

FR001, Vandœuvre-lès-Nancy

59020

FR002, Lille

66421

DE001, Homburg

69008

FR006, Lyon

80054

FR008, Amiens

94805

FR003, Villejuif

2341131

CL001, Valparaíso

7500996

CL004, Santiago

06200

FR005, Nice

4710-243

PT001, Braga

4200-319

PT002, Porto

LS1 3EX

GB005, Leeds

M13 9WL

GB003, Manchester

S10 2TH

GB006, Sheffield

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY